bpc-157 eds BPC 157 in Australia: Benefits, side effects, risks and legality BPC-157 – Research Peptide |

The FDA agenda lists BPC-157, KPV, TB-500, MOTs-C, Emideltide (DSIP), Semax, and Epitalon for discussion as candidates for inclusion on the 503A Bulks List (FDA advisory committee calendar)

The anti-inflammatory properties of BPC-157 appear distinct from standard anti-inflammatory medications

Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance (in Eng)

The inflammatory link between psoriasis and systemic health is underscored by reduced lifespan among those afflicted with this disease: moderate-to-severe psoriasis patients have a 5-year diminished life expectancy

Only a couple of preliminary experiments have involved BPC-157 and animals with pre-existing cancer, which have investigated the potential effects of the peptide on tumor cells